Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue

J Neurooncol. 2010 May;97(3):429-37. doi: 10.1007/s11060-009-0029-8. Epub 2009 Nov 19.

Abstract

The authors describe a 9 month old female with recurrent atypical central neurocytoma and leptomeningeal spread treated with high dose chemotherapy, autologous stem cell rescue, and adjuvant therapy. She had a complete response to therapy and was disease free at 4 years of age until a recurrence 6 months later. The use of intensive chemotherapy followed by autologous stem cell rescue for atypical neurocytoma may be considered as an adjunct to surgical therapy in young patients with atypical neurocytoma not amenable to radiation therapy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms / complications
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / surgery*
  • Female
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Meningeal Neoplasms / complications
  • Meningeal Neoplasms / drug therapy*
  • Meningeal Neoplasms / surgery*
  • Neurocytoma / complications
  • Neurocytoma / drug therapy*
  • Neurocytoma / surgery*
  • Tomography, X-Ray Computed / methods